Please wait...
Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:
USARx offers multiple ways to purchase this medication. Choose the Best option for you!
Combivent Respimat is a metered-dose inhaler containing a combination of albuterol and ipratropium. Albuterol and ipratropium are bronchodilators that relax muscles in the airways and increase air flow to the lungs.
Combivent Respimat is used to prevent bronchospasm (tightening and narrowing of the airways) in people with chronic obstructive pulmonary disease (COPD) who are also using other medicines to control their condition.
Combivent Respimat may also be used for purposes not listed in this medication guide.
You should not use Combivent if you are allergic to albuterol (Proventil, Ventolin), ipratropium (Atrovent), or atropine (Atreza, Lomotil, Vi-Atro, Sal-Tropine).
Before you use this medicine, tell your doctor if you have heart disease, coronary artery disease, a heart rhythm disorder, high blood pressure, seizures, diabetes, thyroid disease, glaucoma, an enlarged prostate, urination problems, liver disease, or kidney disease.
Seek medical attention if you think Combivent is not working as well as usual. Overuse of albuterol and ipratropium may increase the risk of death. It is critical that you use only the prescribed dose of this medicine.
You should not use Combivent if you are allergic to albuterol (Proventil, Ventolin), ipratropium (Atrovent), or atropine.
To make sure Combivent Respimat is safe for you, tell your doctor if you have ever had:
heart disease, coronary artery disease, or heart rhythm disorder;
high blood pressure;
a seizure disorder such as epilepsy;
diabetes;
thyroid disease;
glaucoma;
liver or kidney disease; or
enlarged prostate, problems with urination.
It is not known whether Combivent will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Albuterol and ipratropium inhalation can pass into breast milk. It is unknown whether Combivent Respimat will harm a nursing baby. Tell your doctor if you are breast-feeding before using this medicine.
Combivent Respimat is not approved for use by anyone younger than 18 years old.
Use Combivent Respimat exactly as prescribed by your doctor. Follow the directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.
Combivent Respimat is usually used 4 times per day. Follow your doctor's dosing instructions very carefully.
Overuse of this medicine may increase the risk of death. It is critical that you use only the prescribed dose of this medicine.
Combivent Respimat comes with patient instructions for safe and effective use, and directions for priming the inhaler device. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions. One Combivent Respimat carton contains one cartridge and one inhaler.
To use the Combivent Respimat inhaler:
You do not need to shake the inhaler before use.
Uncap the mouthpiece of the inhaler. Breathe out fully. Put the mouthpiece into your mouth and close your lips. Keep your eyes closed to prevent spraying any medicine into your eyes. Breathe in slowly while pressing the dose-release button on the inhaler. Hold your breath for 10 seconds, then breathe out slowly.
Close the cap until you use your inhaler again.
Carefully follow all directions for cleaning your specific inhaler device once per week.
Keep track of the number of sprays you have used. Throw away the inhaler canister after 3 months or 120 sprays, whichever comes first.
Use Combivent regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.
Seek medical attention if you think this medication is not working as well as usual.
While using Combivent Respimat, you may need medical tests.
Store at room temperature away from moisture, heat, and light. Do not store Combivent Respimat in your car on hot days. Extreme heat can cause the medicine canister to burst. Do not throw an empty canister into open flame.
Combivent Respimat inhalation spray: 1 inhalation 4 times a day
Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 6 in 24 hours.
Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.
Do not use more than 6 inhalations in a 24-hour period.
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of albuterol and ipratropium can be fatal.
Overdose symptoms may include chest pain, fast or pounding heartbeats, tremors, dry mouth, extreme thirst, muscle weakness or limp feeling, severe headache, pounding in your neck or ears, or feeling like you might pass out.
Avoid getting Combivent Respimat in your eyes. If this medication gets in your eyes, rinse with water and seek medical attention.
This medication may cause blurred vision and may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly.
Get emergency medical help if you have signs of an allergic reaction to Combivent Respimat: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
wheezing, choking, or other breathing problems after using this medicine;
chest pain;
fast or pounding heartbeats, fluttering in your chest;
tremors, nervousness;
swelling of your ankles or feet;
blurred vision, tunnel vision, eye pain, or seeing halos around lights;
painful or difficult urination; or
leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling.
Common Combivent Respimat side effects may include:
cold symptoms such as stuffy nose, sneezing, cough, or sore throat;
headache; or
trouble breathing;
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Tell your doctor about all your current medicines and any you start or stop using, especially:
atropine and other “anticholinergic” drugs;
nausea medication (promethazine, scopolamine, others);
medicines for bladder urgency;
diphenhydramine (Benadryl, Advil PM, Unisom, etc.);
diuretics or "water pills";
heart or blood pressure medicine;
beta-blockers (including labetalol, metoprolol, propranolol, others);
antidepressant medications, especially monoamine oxidase inhibitors or MAOs (including isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, tranylcypromine, or methylene blue injection), tricyclic antidepressants (such as amitriptyline, desipramine, doxepin, imipramine, or nortriptyline) as well as paroxetine, nortriptyline and others.;
certain medications for bipolar or schizophrenia such as chlorpromazine, olanzapine, and others;
other inhaled medications.
This list is not complete. Other drugs may interact with albuterol and ipratropium, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Combivent Respimat only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.
Source: Drugs.com Combivent Respimat (www.drugs.com/combivent.html).
Note: This document contains side effect information about albuterol / ipratropium. Some of the dosage forms listed on this page may not apply to the brand name Combivent.
Applies to albuterol / ipratropium: inhalation aerosol powder, inhalation solution, inhalation spray
Along with its needed effects, albuterol/ipratropium may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking albuterol/ipratropium:
More common
Less common
Rare
Incidence not known
Some side effects of albuterol / ipratropium may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
Incidence not known
Applies to albuterol / ipratropium: inhalation aerosol, inhalation solution
Common (1% to 10%): Cough, dyspnea, bronchitis, nasopharyngitis, upper respiratory infection, pharyngolaryngeal pain, wheezing, respiratory disorder, sinusitis, bronchospasm, dysphonia, increased sputum
Rare (less than 0.1%): Laryngospasm
Postmarketing reports: Throat irritation, paradoxical bronchospasm, nasal congestion, pharyngeal edema
Common (1% to 10%): Headache, dizziness, tremor, nervousness, insomnia
Postmarketing reports: Central nervous system stimulation, mental disorder
Common (1% to 10%): Asthenia, influenza -like illness, chest discomfort
Common (1% to 10%): Hypertension, palpitations, tachycardia, arrhythmia, angina, systolic blood pressured increased
Rare (less than 0.1%): Diastolic blood pressure decreased
Postmarketing reports: Myocardial ischemia, supraventricular tachycardia and/or atrial fibrillation
Postmarketing reports: Rash, pruritus, and urticaria (including giant urticaria), angioedema including that of tongue, lips and face, laryngospasm, and anaphylactic reaction
Common (1% to 10%): Eye pain
Postmarketing reports: Glaucoma, blurred vision, mydriasis, conjunctival hyperemia, halo vision, accommodation disorder, ocular irritation, corneal edema, intraocular pressure increased
There are numerous case reports in the literature of precipitation of glaucoma with the use of ipratropium and albuterol via nebulized solution. This is thought to occur through direct contact with the eyes, and is seen with the combination since both beta agonists and anticholinergics can increase intraocular pressure. There is one report of glaucoma associated with the use of nebulized albuterol and ipratropium aerosol in an emergency department. Caution is warranted when the combination is used in patients predisposed to glaucoma. Extra care should be taken to avoid contact with the eyes.
Common (1% to 10%): Diarrhea, nausea, dry mouth, constipation, vomiting, dyspepsia, taste perversion, dry throat
Postmarketing reports: Gastrointestinal motility disorder (e.g., diarrhea), drying of secretions, stomatitis, mouth edema
Common (1% to 10%): Muscle spasms, myalgia, arthralgia
Postmarketing reports: Muscular weakness
Common (1% to 10%): Hypokalemia
Frequency not reported: Lactic acidosis
Common (1% to 10%): Pruritus, rash
Postmarketing reports: Angioedema, hyperhidrosis, skin reaction
Common (1% to 10%): Urinary tract infection, dysuria
Postmarketing reports: Urinary retention
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.
Source: Drugs.com Combivent Respimat (www.drugs.com/combivent.html).
June 26, 2020
June 25, 2020
June 27, 2020
July 10, 2020
July 9, 2020
July 1, 2020
